Cory berkland

Cory Berkland. 2004, Journal of Controlled Release. A thorough understanding of the factors affecting drug release mechanisms from surface-erodible polymer devices is critical to the design of optimal delivery systems. Poly(sebacic anhydride) (PSA) microspheres were loaded with three model drug compounds (rhodamine B, p-nitroaniline and ...

How it works: Cory Berkland, Ph.D., professor at the University of Kansas, is a serial entrepreneur, co-founding Orbis Biosciences, Savara Pharmaceuticals and Orion Biosciences, as well as co-developing several technologies with industry partners. In late 2012, IAMI invested in novel polymer technology discovered by Dr. Berkland with the intent ...Brad Spitz, Nathan Dormer & Cory Berkland are part of Orbis Biosciences leadership, Maria Stecklein Flynn is the CEO.Cory BERKLAND | Cited by 10,054 | of University of Kansas, Kansas (KU) | Read 244 publications | Contact Cory BERKLANDBerkland C, Kim K, Pack DW. PLG microsphere size controls drug release rate through several competing factors . Pharmaceutical Research . 2003 Jul 1;20(7):1055-1062. doi: 10.1023/A:1024466407849 Fah Chueahongthong; Singkome Tima; Sawitree Chiampanichayakul; Cory Berkland; Songyot Anuchapreeda: 1-Sep-2021: Correction to: Effect of fluoroscopic X-rays combined with iodinated radiographic contrast media on human hematological parameters (Toxicology and Environmental Health Sciences, (2021), 13, 3, (225-235), 10.1007/s13530-021-00093-7)1. INTRODUCTION. Hyaluronic acid (HA) is a linear biopolymer component of multiple approved products and exhibits versatility for drug delivery, since it is available in a wide range of molecular weights and offers multiple sites for chemical modification. 1–6 In the human body, HA is prevalent in cartilage, skin, and synovial fluid and is typically …Cory Berkland. The Berkland Lab investigates pharmaceuticals and biomaterials. They aim to understand the transport of pharmaceuticals as a function of physical and chemical properties. Biomaterials are also investigated for applications in regenerative medicine. Faculty Profile. Berkland Research Lab.

Biography —. Distinguished Professor of Chemical and Petroleum Engineering and Pharmaceutical Chemistry.Dr. Hartwell obtained her PhD in biomolecular engineering with Cory Berkland at the University of Kansas as a Madison and Lila Self Graduate Fellow. Her doctoral research focused on developing an antigen-specific immunotherapy to treat multiple sclerosis while determining cellular and molecular mechanisms of tolerance.CORY BERKLAND. Administrator. See All Contacts. Dynamic search and list-building capabilities. Real-time trigger alerts. Comprehensive company profiles. Valuable research and technology reports. Get a D&B Hoovers Free Trial. Financial Data. Dun & Bradstreet collects private company financials for more than 23 million companies worldwide.Sentinel lymph node (SLN) mapping has been widely used to predict the metastatic spread of primary tumor to regional lymph nodes in clinical practice. In this research, a new near-infrared (NIR)-emitting polymer nanogel (NIR-PNG) having a hydrodynamic diameter of about 30 nm, which is optimal for lymph node uptake, was developed. The NIR-emitting …Cory Berkland. The University of Kansas. ... CJ Berkland, ML Forrest. Advanced drug delivery reviews 61 (6), 457-466, 2009. 897: 2009: Nanotechnology in vaccine delivery. Title: FLT3-specific curcumin micelles enhance activity of curcumin on FLT3-ITD overexpressing MV4-11 leukemic cells: Authors: Singkome Tima Siriporn OkonogiCory Berkland. [email protected]; Department of Chemical and Petroleum Engineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, …

Collaborators: Michael Detamore, Jenn-Tai Liang, Paul Willhite, Teruna Siahaan, others! Postdocs: Jian Qian, Sheng-Xue Xie, Huili Guan, Nashwa El-Gendy, Ying-Ying Lin,... Cory J. Berkland,1,4 Cato T. Laurencin,2,3,5 and Michael S. Detamore6. 1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66045 ...El-Gendy Nashwa, Huang Shan, Selvam Parthiban, Soni Pravin, Berkland Cory. Development of Budesonide NanoCluster Dry Powder Aerosols: Formulation and Stability. Journal of Pharmaceutical Sciences. 2012; 101 (9):3445-3455. [Google Scholar] 38. El-Gendy Nashwa, Huang Shan, Selvam Parthiban, Soni Pravin, Berkland Cory. ...BERKLAND CORY, MOHAMMADI ZAHRA. Author information. Affiliations. All authors. 1. UNIV KANSAS Patent: Publ.of the Int.Appl. with Int.search report - World Intellectual Property Organization Application: WO2011US26872 on 02 Mar 2011 Publication: 02 Mar 2011 PAT: WO2011109521 ...

Costco procter and gamble rebate 2023.

Cory Berkland. [email protected]; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047. Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047Search for more papers by this authorCory Berkland. Solon E. Summerfield Distinguished Professor; Department of Pharmaceutical Chemistry; Contact Info. [email protected]. 785-864-1455. Cory Berkland is a professor of pharmaceutical chemistry and chemical and petroleum engineering at the University of Kansas. (Berkland Tr. 593) The Court recognized Dr. Berkland as an expert in the preparation and analysis of pharmaceutical formulations.Introduction. Advancements in treating autoimmune diseases such as multiple sclerosis (MS) have been made by enhancing our understanding of the molecular processes involved in disease progression. 1,2 The complexity of immune responses and the heterogeneous nature of immune cells complicate the design of therapeutics. In the case …Cory Berkland, Ph.D. Abstract Basic principles have emerged for oral and intravenous drug design, but fewer efforts have ... Berkland is a co-founder of Orbis Biosciences (purchased by Adare Pharmaceuticals), Savara Pharmaceuticals (NASDAQ: SVRA), Bond Biosciences, and Orion BioScience. Title: Microsoft Word - Cory Berkland Seminar Announcement ...

Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...Cory Berkland View For the in vitro release experiment, 50 µl of UM-3003 adsorbed alhydrogel formulation was mixed with 500 µl of adjuvant-free human plasma in a closed glass vial at 37 °C and ...Targeted gene delivery using nonviral vectors is a highly touted scheme to reduce the potential for toxic or immunological side effects by reducing dose. In previous reports, TAT polyplexes with DNA have shown relatively poor gene delivery. The transfection efficiency has been enhanced by condensing …24‏/02‏/2023 ... , and; Cory J. Berkland*. Cory J. Berkland. Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States. Department ...Congratulations to our collaborator, Prof. Cory Berkland, who was recognized last week with the Jim Baxendale Commercialization Award! Prof. Berkland...Cory Berkland [email protected] Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047. Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas …Cory Berkland, Corresponding Author. [email protected]; Department of Chemical and Petroleum Engineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047.Cory Berkland, Ph.D. Date. Friday, January 29, 2021 - 12:00pm. Location. University of Houston. Abstract. Basic principles have emerged for oral and intravenous drug design, but fewer efforts have aimed to create drugs that persist at the administration site or molecular structures thatGlobalization of Pharmaceutics Education Network (GPEN) Founded in 1996 by the KU Department of Pharmaceutical Chemistry in cooperation with several educational institutions in Europe and Asia, GPEN, Inc. was created for the sole purpose of fostering and facilitating international scientific exchange in the pharmaceutical sciences.

Cory Berkland Mario Rivera Kate ESHELMAN Jian QIAN Nashwa EL-GENDY Original Assignee The University Of Kansas Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2014-10-10 Filing date 2015-10-08 Publication ...

Introduction. Fibroblast growth factor-10 (FGF-10), also known as keratinocyte growth factor-2 (KGF-2), is a 208 amino acid polypeptide (M w 19,000) belonging to the FGF family. These structurally related proteins bind to polyanions including heparin and are involved in a variety of physiological and pathological processes [].FGF-10 activities include epithelial cell proliferation and ...Dr. Richard Hopkins is a Thoracic Surgeon in Kansas City, MO. Find Dr. Hopkins's phone number, address, insurance information, hospital affiliations and more.Complexes were formed by addition of appropriate volumes of pDNA and TAT with or without CaCl 2 (15 μL of 113 mM CaCl 2) or PEI solutions calculated to produce the desired molar ratio, followed by a 20 min incubation at 4 °C prior to use (Baoum and Berkland, 2011). Complexes were freshly prepared before each individual analysis. 2.3.Cory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab.BME Faculty Directory. Cardiovascular Engineering. Orthopedic Engineering. Women's Health Technologies.Ruolin Lu, 1 Chad Groer, 2 Peter A. Kleindl, 1 K. Ryan Moulder, 1 Aric Huang, 1 Jordan R. Hunt, 1 Shuang Cai, 1, 2 Daniel J. Aires, 2, 3 Cory Berkland, 1 and Laird Forrest 1, 2, * Ruolin Lu 1 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KansasCorrespondence to: C. Berkland (e-mail: [email protected])Search for more papers by this author. Amir Fakhari, ... Search for more papers by this author. Cory Berkland, Corresponding Author. Bioengineering Graduate Program, University of Kansas, Lawrence, Kansas. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas.Dr. Cory Berkland is Chairman of the Board, President, CEO, and Co-Founder of Bond Biosciences. He is Distinguished Professor at The University of Kansas and has …

Trent smiley.

Robert barnhill.

Cory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab.KU chemical and petroleum engineering associate professors Michael Detamore and Cory Berkland are collaborating on the project that could revolutionize the repair and treatment of degenerated cartilage. "Cartilage doesn't really heal well on its own," Detamore said. "It's not like bone where you put it in a cast, wait six weeks and ...Cory Berkland holds the Solon E. Summerfield Distinguished Professorship in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas. He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS ...J Pharm Innov (2010) 5:70-71 DOI 10.1007/s12247-010-9084- EDITORIAL Cory Berkland Published online: 16 July 2010 # Springer Science+Business Media, LLC 2010 In the pharmaceutical community, nanotechnology has that particles with a diameter larger than about 10 nm may become the flavor of the day for anything with a size or persist in circulation due to exclusion from renal filtration ...1. Introduction to hyaluronic acid. Hyaluronic acid (HA), also named hyaluronan, is a high molecular weight (10 5 –10 7 Da) naturally occurring biodegradable polymer. HA is an unbranched non-sulfated glycosaminoglycan (GAG) composed of repeating disaccharides (β-1,4-D-glucuronic acid (known as uronic acid) and β-1,3-N-acetyl-D-glucosamide) …Cory Berkland. Corresponding Author. E-mail address: [email protected]. Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047.Chandrashekar Raman 1 , Cory Berkland, Kyekyoon Kim, Daniel W Pack. Affiliation 1 Department of Chemical and Biomolecular Engineering, University of Illinois, Urbana, IL 61801, United States. PMID: 15773062 DOI: 10.1016/j.jconrel.2004.11.012 Abstract Modeling release of small molecules from degradable microspheres is important to the design of ...Cory Berkland [email protected] Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047. Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047Search for more papers by this authorThe most common forms of proteosomes used for vaccine applications are nanoparticles composed of the outer membrane proteins (OMPs) of Neisseria meningitidis. OMPs have been used successfully in a marketed meningococcal vaccine since 1981 and are considered non-toxic and well-tolerated [160], [161].He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa State University in Ames. Prof. Berkland is a co-founder of Orbis Biosciences, Savara Pharmaceuticals, Bond Biosciences and Orion BioScience.Brittany L. Hartwell, Chad J. Pickens, Martin Leon, and Cory Berkland . Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis. Biomacromolecules 2017, 18 (6) , 1893-1907. DOI: 10.1021/acs.biomac.7b00335. ... ….

Chandrashekar Raman 1 , Cory Berkland, Kyekyoon Kim, Daniel W Pack. Affiliation 1 Department of Chemical and Biomolecular Engineering, University of Illinois, Urbana, IL 61801, United States. PMID: 15773062 DOI: 10.1016/j.jconrel.2004.11.012 Abstract Modeling release of small molecules from degradable microspheres is important to the design of ...Chad Groer, 1 Ti Zhang, 1 Ruolin Lu, 2 Shuang Cai, 1 Derek Mull, 1 Aric Huang, 2 Melanie Forrest, 1 Cory Berkland, 2, 3 Daniel Aires, 1, 4 and Marcus Laird Forrest 1, 2, * Chad Groer 1 HylaPharm LLC, Lawrence, KansasAs part of the BME seminar series, join us for this presentation by Cory Berkland, Solon E. Summerfield Distinguished Professorship in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas. This seminar will be virtual. Register for this event by going here. Abstract: Effective delivery of drugs to therapeutic targets requires an ...Min Huang 1 , Samadhi N Vitharana, Laura J Peek, Tina Coop, Cory Berkland. Affiliation 1 Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, USA. PMID: 17428030 DOI: 10.1021/bm061211k Abstract Angiogenesis has long been a desired therapeutic approach to improve clinical outcomes of conditions typified by ...Singkome Tima; Siriporn Okonogi; Chadarat Ampasavate; Cory Berkland; Songyot Anuchapreeda: 1-Jan-2009: HPLC determination of mangostin and its application to storage stability study: Pathom Jujun; Krisana Pootakham; Yanee Pongpaibul; Prasit Tharavichitkul; Chadarat Ampasavate: 16-Feb-2016OTM Office Hours: Cory Berkland (University of Kansas), Heidi Hope (Confluence Discovery Technologies), Ryan Sullivan (Curie.Bio) - "Idea to Drug" July 13, 2023. 3:00 pm - 4:00 pm. Department/Center/Program Seminars, Upcoming. @4240 Duncan Avenue, suite 110 (Cortex Campus) Add to ...Jun Yang, 1, 2 Sheng-Xue Xie, 3 Yiling Huang, 1, 4 Min Ling, 1 Jihong Liu, 2 Yali Ran, 1 Yanlin Wang, 4 J Brantley Thrasher, 1 Cory Berkland, 3 and Benyi Li *, 1, 4 ... C Berkland would like to acknowledge supports for the project from the Coulter Foundation, the NIH (AR054035) and the NSF (0966614).Supang Khondee, Tatyana Yakovleva, Cory Berkland. First published: 04 August 2010. https://doi.org/10.1002/app.32460. Citations: 2. Read the full text. PDF. … Cory berkland, [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1]